Maternal and Clinical Outcomes of Placenta Accreta Spectrum: Insights from a Retrospective Study in Bahrain
- PMID: 40566629
- PMCID: PMC12194568
- DOI: 10.3390/life15060978
Maternal and Clinical Outcomes of Placenta Accreta Spectrum: Insights from a Retrospective Study in Bahrain
Abstract
Placenta accreta spectrum (PAS) refers to a group of abnormal placental attachments in which the placenta adheres too deeply to the uterine wall, with varying degrees of invasion classified as accreta, increta, or percreta. Increased rates of uterine surgeries, advanced maternal age, and cesarean deliveries have all contributed to an increase in the incidence of PAS. Complications associated with PAS can lead to severe intrapartum or postpartum hemorrhage, hysterectomy, and significant maternal morbidity, making early diagnosis and management crucial for improving outcomes. Understanding the epidemiology and risk factors of PAS is crucial for developing early detection protocols and preventive strategies. Localized data, particularly from Bahrain, can inform targeted care approaches and optimize resource allocation, ultimately leading to improved clinical guidelines, enhanced patient education, and better healthcare outcomes for affected women. There are growing concerns about the impact of PAS on maternal health and healthcare resources in Bahrain, similar to trends observed in other regions. To improve patient education and management strategies, it is essential to comprehend the regional patterns, characteristics, and outcomes associated with PAS. However, the absence of comprehensive data specific to Bahrain hinders effective clinical decision-making and policy development. Addressing this gap is imperative for advancing maternal healthcare in the region.
Keywords: cesarean delivery; maternal morbidity; obstetric complications; placenta accreta spectrum (PAS); placenta previa.
Conflict of interest statement
The authors declare no conflicts of interest.
Similar articles
-
Risk factors, prenatal diagnosis, and outcome of posterior placenta accreta spectrum disorders in patients with placenta previa or low-lying placenta: A multicenter study.Acta Obstet Gynecol Scand. 2025 Jul;104(7):1328-1338. doi: 10.1111/aogs.15132. Epub 2025 May 19. Acta Obstet Gynecol Scand. 2025. PMID: 40387324 Free PMC article.
-
Urological complications in women undergoing Cesarean section for placenta accreta spectrum disorders: systematic review and meta-analysis.Ultrasound Obstet Gynecol. 2023 Nov;62(5):633-643. doi: 10.1002/uog.26299. Ultrasound Obstet Gynecol. 2023. PMID: 37401769
-
Prenatal ultrasound diagnosis and outcome of placenta previa accreta after cesarean delivery: a systematic review and meta-analysis.Am J Obstet Gynecol. 2017 Jul;217(1):27-36. doi: 10.1016/j.ajog.2017.02.050. Epub 2017 Mar 6. Am J Obstet Gynecol. 2017. PMID: 28268196
-
The role of the intraplacental fetal artery in predicting the need for cesarean-hysterectomy in women at high risk for placenta accreta spectrum.Placenta. 2025 Jan;159:154-160. doi: 10.1016/j.placenta.2024.12.013. Epub 2024 Dec 20. Placenta. 2025. PMID: 39724757
-
Contemporary Placenta Accreta Spectrum Disorder Incidence and Risk Factors.Obstet Gynecol. 2025 Jun 1;145(6):665-673. doi: 10.1097/AOG.0000000000005919. Epub 2025 Apr 17. Obstet Gynecol. 2025. PMID: 40245410
References
-
- Hecht J.L., Baergen R., Ernst L.M., Katzman P.J., Jacques S.M., Jauniaux E., Khong T.Y., Metlay L.A., Poder L., Qureshi F., et al. Classification and reporting guidelines for the pathology diagnosis of placenta accreta spectrum (PAS) disorders: Recommendations from an expert panel. Mod. Pathol. 2020;33:2382–2396. doi: 10.1038/s41379-020-0569-1. - DOI - PubMed
-
- American College of Obstetricians and Gynecologists. Society for Maternal-Fetal Medicine Obstetric Care Consensus, No.7: Placenta Accreta Spectrum. Obstet. Gynecol. 2018;132:e259–e275. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous